Leveraging biomaterials for cancer immunotherapy: targeting pattern recognition receptors
- 11 February 2019
- journal article
- review article
- Published by Elsevier BV in Materials Today Nano
- Vol. 5, 100029
- https://doi.org/10.1016/j.mtnano.2019.100029
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (51673185, 51673189, 51833010, 51520105004)
- Program of Scientific Development of Jilin Province (20170101100JC)
- National Key Research and Development Program of China (2016YFC1100701)
This publication has 170 references indexed in Scilit:
- Chitosan-coated boron nitride nanospheres enhance delivery of CpG oligodeoxynucleotides and induction of cytokinesInternational Journal of Nanomedicine, 2013
- Differential Ligand Binding Affinities of Human Estrogen Receptor-α IsoformsPLOS ONE, 2013
- Membrane Anchored Immunostimulatory Oligonucleotides for In Vivo Cell Modification and Localized ImmunotherapyAngewandte Chemie-International Edition, 2011
- Immune Signaling by RIG-I-like ReceptorsImmunity, 2011
- Pattern Recognition Receptors and InflammationCell, 2010
- In Vitro Analysis of Acetalated Dextran Microparticles as a Potent Delivery Platform for Vaccine AdjuvantsMolecular Pharmaceutics, 2010
- RNA Polymerase III Detects Cytosolic DNA and Induces Type I Interferons through the RIG-I PathwayCell, 2009
- The NLRP3 Inflammasome Mediates In Vivo Innate Immunity to Influenza A Virus through Recognition of Viral RNAImmunity, 2009
- Recognition of Cytosolic DNA Activates an IRF3-Dependent Innate Immune ResponseImmunity, 2006
- A Toll-like receptor–independent antiviral response induced by double-stranded B-form DNANature Immunology, 2005